Revisiting prophylaxis of homeopathic interventions in COVID 19

Authors

DOI:

https://doi.org/10.51910/ijhdr.v20i4.1098

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused by novel beta-coronavirus has emerged as a cause of coronavirus pandemic (COVID-19) declared by Public Health Emergency of International Concern (PHEIC). Korean oriental medicine, Traditional Chinese Medicine (TCM), and Indian systems of medicine known as AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Sowa-Rigpa and Homeopathy) had implemented various prophylactic measures and interim treatment guidelines in prevention and treatment for COVID -19 cases. However, even though different approaches were implemented to break the epidemic chain, we have not reached herd effect or herd immunity in the Indian population. Therefore, in this ongoing COVID-19 pandemic, a specific study on immune markers of IL-6 (Interleukin-6), D-Dimer, Ferritine, CRP (C-reactive protein) with SARS CoV-2 specific IgG & IgM antibodies need to be investigated for generating hard-core evidence for homeoprophylaxis in terms of immunity response. Therefore, there seems to be a need to revisit the program of homeoprophylaxis in the COVID -19 pandemic.

Author Biography

Aditya Dilipkumar Patil, Bharati Vidyapeeth

Post Graduate Scholar in Homeopathic Pharmacy at Bharati vidyapeeth homeopathic medical College and hospital. Pune, Maharashtra, India

Downloads

Published

2022-01-02

Issue

Section

Letters to the Editor